NCT05981196Recruiting

Disparities Among Liver Transplant Patients

Mayo Clinic

Start Date

11/15/2023

Completion Date

7/1/2026

Summary

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Detailed Description

Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction. Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender). Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).

Eligibility Criteria

Age Range: 18 years to 65 years

Inclusion Criteria: \- Patients with end-stage liver, kidney, or cardiac dysfunction. Exclusion Criteria: * Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant. * Patients with potential medical exclusions for transplant.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

End Stage Liver DIsease

Locations

Mayo Clinic Arizona

Phoenix, Arizona 85054

United States